2.
不同临床特征下蛋白尿和CKD的患病率比较
Prevalence of proteinuria and CKD in individuals with different clinical characteristics
| variables | Albuminuria | CKD | RI | |||
| Total (%) | Microalbuminuria (%) | Macroalbuminuria (%) | CKD n (%) | RI n (%) | ||
| #P < 0.05 female versus male; aP < 0.05 50-59、60-69 or ≥70 versus 40-49; bP < 0.05 40-49、60-69 or ≥70 versus 50-59; cP < 0.05 40-49、50-59 or ≥70 versus 60-69; *P < 0.05 known diabetes versus newly diagnosed diabetes; hypertension versus normotension; Obesity versus non-Obesity; ‡P < 0.05 diabetes versus NGT; §P < 0.05 diabetes versus IGR. | ||||||
| n (%) | 2625 (26.2) | 2544 (25.3) | 81 (0.8) | 2748 (27.4) | 251 (2.5) | |
| Male | 570 (19.6) | 537 (18.5) | 33 (1.1) | 599 (20.6) | 54(1.9) | |
| Female | 2055 (28.8)# | 2007 (28.1)# | 48 (0.7)# | 2149 (30.1)# | 197 (2.7)# | |
| Age group (year) | ||||||
| 40-49 | 312(17.0)bc | 306(16.7)bc | 6 (0.3)bc | 317 (11.5)bc | 11 (4.4)bc | |
| 50-59 | 874 (22.1)ac | 854 (21.6)ac | 20 (0.5)ac | 905 (32.9)ac | 58 (23.1)ac | |
| 60-69 | 939(31.1)ab | 903(29.9)ab | 36(1.2)ab | 979(35.6)ab | 90 (35.8)ab | |
| ≥70 | 500 (40.8)abc | 481 (39.2)abc | 19 (1.5)abc | 547 (19.9)abc | 92 (36.7)abc | |
| NGT (n=4744) | 1020 (21.5) | 1003 (21.2) | 17 (0.4) | 1066 (22.5) | 87(1.8) | |
| Hypertention (n=1245) | 349(28.0)* | 335(26.9)* | 14(1.1)* | 366(29.4)* | 39 (3.1)* | |
| Normotention (n=3499) | 671 (19.2) | 668 (19.1) | 3(0.1) | 700 (20.0) | 48(1.4) | |
| Obesity | 35(25.2) | 33(23.7) | 2 (1.4)* | 41 (29.5)* | 9 (6.5)* | |
| Non-obesity | 985 (21.4) | 970 (21.1) | 15 (0.3) | 1025 (22.3) | 78(1.7) | |
| IGR (n=2808) | 724 (25.8) | 714 (25.4) | 10 (0.4) | 758 (27.0) | 69(2.5) | |
| Isolated-IFG (n=430) | 89(20.7) | 87(20.2) | 2(0.5) | 95(22.1) | 11(2.7) | |
| Isolated-IGT (n=1734) | 455 (26.2) | 450 (26.0) | 5(0.3) | 479 (27.6) | 46(2.7) | |
| Combined-IGT (n=644) | 180 (28.0) | 177 (27.5) | 3(0.5) | 184 (28.6) | 12(1.9) | |
| Obesity | 52 (31.3)* | 51 (30.7)* | 1 (0.6)* | 55 (33.1)* | 7 (4.2)* | |
| non-Obesity | 672 (25.4) | 663 (25.1) | 9(0.3) | 703 (26.6) | 62(2.3) | |
| Hypertention | 373(32.3)* | 366(31.7)* | 7 (0.6)* | 392(33.9)* | 46 (4.0)* | |
| Normotention | 351 (21.2) | 348 (21.1) | 3(0.2) | 366 (22.2) | 23(1.4) | |
| T2DM (n=2486) | 881(35.4)ठ| 827(33.3)ठ| 54(2.2)ठ| 924(37.2)ठ| 113(4.5)ठ| |
| Known (n=1168) | 469(40.2)* | 419(35.9)* | 50(4.3)* | 495(42.4)* | 80 (6.8)* | |
| Newly diagnosed (n=1318) | 412 (31.3) | 408 (31.0) | 4(0.3) | 429 (32.5) | 33(2.5) | |
| Obesity | 54(37.5) | 51(35.4) | 3(2.1) | 58(40.3) | 7 (4.9) | |
| non-Obesity | 827 (35.3) | 776 (33.1) | 51 (2.2) | 866 (37.0) | 106 (4.5) | |
| Hypertention | 528(39.5)* | 486(36.4)* | 42(3.1)* | 559(41.8)* | 89 (6.7)* | |
| Normotention | 353 (30.7) | 341 (29.7) | 12 (1.0) | 365 (31.8) | 24(2.1) | |